Cardiovascular Consequences After COVID-19

• Conditions: Cardiovascular Consequences After an Episode of COVID 19
• Interventions: Other: Infectious Disease and Cardiology Clinical Consultations

• Registration Number: NCT04452630
• Lead Sponsor: Assistance Publique Hopitaux De Marseille

Brief Summary

The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coronavirus.

The lack of characterization of cardiovascular damages linked to Covid-19 could have medium and long-term consequences on the prognosis of patients. This problematic could lead to a second major public health problem linked to Covid-19 and it is therefore crucial to keep monitoring and screening patients at risk.

In this context of emerging infectious diseases, of poorly characterized cardiovascular damages during infection and of absence of data on the long-term evolution of the infection, the investigators propose to carry out a prospective and observational cohort study focused on the evaluation and the systematic cardiovascular follow up of patients who survived an episode of Covid-19, regardless of their cardiovascular profiles.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-06
• Study Start: 2020-06-23
• Study First Submitted: 2020-06-26
• Study First Submitted QC: 2020-06-26
• Last Update Submitted: 2020-06-26
• Study First Posted: 2020-06-30
• Last Update Posted: 2020-06-30
• Primary Completion: 2020-07-23
• Study Completion: 2021-11-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• All adults affiliated to social security attending the post-Covid follow-up consultation, having presented an episode of Covid-19 diagnosed by at least one positive nasopharyngeal RT-PCR test for SARS-Cov-2 and considered recovered.

Exclusion Criteria

• Age <18 years old
• Major under guardianship or curatorship
• Absence of non-opposition

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Covid 19 Patients	Infectious Disease and Cardiology Clinical Consultations	patients having presented an episode of Covid-19 diagnosed by at least one positive nasopharyngeal RT-PCR test for SARS-Cov-2 and considered recovered.

Primary Outcome Measures

Name	Time	Method
Presence of at least one clinical, biological and/or imaging cardiovascular anomaly within 1 month of recovering	1 month	Describe clinical, biological and imaging cardiovascular data 1 month after recovery from an episode of Covid-19

Trial Locations

Locations (1)

Assistance Publique Hôpitaux de Marseille; 🇫🇷 Marseille, France